Canadian Meds |
Policy | Legal
Terms | Meds Index
What is glaucoma?
Glaucoma is a widespread disease. The main cause of it is high intraocular pressure, leading to progressive glaucomatous optic nerve atrophy. It should be noted, that modern ways of therapy lead to a complete cure of glaucoma and among them is Travoprost Ophthalmic Solution.
But, all patients should be aware that curing is administered to stop or slow the progressive decline in the patient's vision. Glaucoma treatment will be more effective if you detect it in time and choose an adequate treatment.
Glaucoma treatment can be divided into two types:
1. Aimed at reducing intraocular pressure (Travoprost Ophthalmic Solution);
2. Designed to improve circulation and stimulate recovery (regenerative) processes of optic nerve damage choice therapy with Travoprost Ophthalmic Solution);
There are few medical methods to reduce intraocular pressure, among which is laser and general surgery. Each of these methods has its indications and contraindications. But, Travoprost Ophthalmic Solution is absolutely safe for all groups of patients.
Prostaglandins (biologically active substances related to hormones) mechanism of action is characterized by increase of the permeability of the pores through which the corner of the anterior chamber intraocular fluid flows away from the eye Travoprost Ophthalmic Solution (Travatan).
What is Travoprost Ophthalmic Solution?
Travoprost - a new prostaglandin, which has won popularity among doctor and patients with glaucoma.
Increased intraocular pressure (IOP) has been proved to be the leading risk factor in the development of such unpleasant eye condition.
Patients with ocular hypertension or open-angle glaucoma are often prescribed to take Travoprost Ophthalmic Solution to lower intraocular pressure.
How does Travoprost Ophthalmic Solution work?
Travoprost Ophthalmic Solution drug (0. 004% eye drops) has been introduced into clinical practice in 2001. Like other prostaglandins, it, absorbing through the cornea, is hydrolyzed and proceeds from the inactive to the active form, boosting a hypotensive effect.
How should you apply Travoprost Ophthalmic Solution?
Adults, including the elderly: 1 drop into the conjunctival sac of the affected eye 1 time a day. Optimal effect is achieved when the dose is taken in the evening.
If a dose of Travoprost Ophthalmic Solution is missed, donít worry. Just continue your treatment and take it according to the scheduled. Dose should not be exceeded one drop once a day.
For patients with impaired liver and kidney function the dose adjustment is not required.
Results of Travoprost Ophthalmic Solution clinical studies.
Clinical research, conducted on among the wide range of primary open-angle glaucoma patients, showed that Travoprost Ophthalmic Solution in its hypotensive activity not inferiors, and in some cases exceeds other effective eye drops. Even a single application of Travoprost Ophthalmic Solution reduces intraocular pressure, compared to popular timolol 0. 5% eye drops. In all the clinical trials reduction of intraocular pressure has been notices in 30% primary open-angle glaucoma and ocular hypertension patients.
The clinical studies and medical trials have indicated an important risk factor for glaucomatous lesions due to significant diurnal fluctuations in intraocular pressure. Travoprost Ophthalmic Solution provides not only a stable hypotensive action within 84 hours, but also has the minimum daily variation of IOP.
Travoprost Ophthalmic Solution is suitable for long-term control of intraocular pressure.
© 2003-2017 Rx Meds Canada . All Rights Reserved